Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Keybanc Downgrades Meta Platforms to Sector Weight

Keybanc Downgrades Meta Platforms to Sector Weight

Keybanc analyst Justin Patterson downgrades Meta Platforms (NASDAQ:META) from Overweight to Sector Weight.

byBenzinga Newsdesk

October 27, 2022

1 minute read

Keybanc analyst Justin Patterson downgrades Meta Platforms (NASDAQ:META) from Overweight to Sector Weight.

Morgan Stanley Earnings Conference Call Is Coming Up, Here’s What You Need To Know

By Benzinga Insights

July 7, 6:55 AM

Morgan Stanley (NYSE:MS) will host a conference call at 09:30 AM ET on July 14, 2022, to discuss Q2 2022 earnings results.

Relmada Shares Nosedive As Another Depression Trial Goes Up In Smoke

By Vandana Singh

December 8, 9:12 AM

Relmada Therapeutics Inc (NASDAQ:RLMD) announced the results of the RELIANCE I REL-1017-301 study evaluating REL-1017 as an adjunctive treatment…

RLMD

Oramed Pharma Shares Fall After Additional Data From Oral Insulin Study

By Vandana Singh

November 17, 2:12 PM

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) has announced additional data from its Phase 2 trial (ORA-D-N02) of oral insulin candidate (ORMD-0801) to reduce…

ORMP

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis’ Sandoz Inks Pact With Samsung Bioepis

By Vandana Singh

September 11, 9:32 AM

Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has

ABBV

Keybanc Downgrades Meta Platforms to Sector Weight

Related Posts

Morgan Stanley Earnings Conference Call Is Coming Up, Here’s What You Need To Know

Relmada Shares Nosedive As Another Depression Trial Goes Up In Smoke

Oramed Pharma Shares Fall After Additional Data From Oral Insulin Study

Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis’ Sandoz Inks Pact With Samsung Bioepis